SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004396
Filing Date
2019-04-01
Accepted
2019-04-01 08:56:26
Documents
94
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1311080
2 ex4-11.htm EX-4.11 151069
3 ex4-12.htm EX-4.12 149151
4 ex10-13.htm EX-10.13 96117
5 ex10-18.htm EX-10.18 88575
6 ex10-47.htm EX-10.47 625952
7 ex23-1.htm EX-23.1 4888
8 ex31-1.htm EX-31.1 11759
9 ex32-1.htm EX-32.1 6732
  Complete submission text file 0001493152-19-004396.txt   6868846

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE xtnt-20181231.xml EX-101.INS 917113
11 XBRL SCHEMA FILE xtnt-20181231.xsd EX-101.SCH 61023
12 XBRL CALCULATION FILE xtnt-20181231_cal.xml EX-101.CAL 102001
13 XBRL DEFINITION FILE xtnt-20181231_def.xml EX-101.DEF 221573
14 XBRL LABEL FILE xtnt-20181231_lab.xml EX-101.LAB 450422
15 XBRL PRESENTATION FILE xtnt-20181231_pre.xml EX-101.PRE 368623
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34951 | Film No.: 19718945
SIC: 2836 Biological Products, (No Diagnostic Substances)